がん診断の世界市場分析:タイプ別(臨床検査、遺伝検査、画像検査、内視鏡検査)、用途別(乳房、肺、肝臓、子宮頸、結腸直腸、皮膚)、地域別、セグメント予測、2014 – 2025

Grand View Researchが発行した調査報告書(GVIEW707153)
◆英語タイトル:Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014-2025
◆商品コード:GVIEW707153
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2017年3月15日
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、がん診断の世界市場について調査・分析し、がん診断の世界市場動向、がん診断の世界市場規模、市場予測、セグメント別がん診断市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.
Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.

The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.

In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of cancer cases
3.2.2 Technological advancement
3.2.3 Initiatives undertaken by government
3.2.4 Reimbursement coverage
3.3 Market Restraints Analysis
3.3.1 Lack of sensitivity and specificity
3.3.2 Risk of high radiation exposure used in different treatments
3.3.3 Cost of diagnosis
3.4 Penetration & growth prospect mapping
3.5 Cancer Diagnostics – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Cancer Diagnostics: Screening Type Estimates & Trend Analysis
4.1 Cancer Diagnostics Market: Screening Type movement analysis
4.1.1. Laboratory Tests
4.1.1.1 Laboratory Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.2 Genetic Tests
4.1.2.1 Genetic Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.3 Imaging
4.1.3.1 Imaging Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.4 Endoscopy
4.1.4.1 Endoscopy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.5 Biopsy
4.1.5.1 Biopsy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.6 Others ( Barium Enema)
4.1.6.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 5 Cancer Diagnostics: Application Estimates & Trend Analysis
5.1 Cancer Diagnostics Market: Application movement analysis
5.1.1 Breast Cancer
5.1.1.1 Breast Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.2 Colorectal Cancer
5.1.2.1 Colorectal Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.3 Cervical Cancer
5.1.3.1 Cervical Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.4 Lung Cancer
5.1.4.1 Lung Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.5 Prostate cancer
5.1.5.1 Prostate Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.6 Skin Cancer
5.1.6.1 Skin Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.7 Blood Cancer
5.1.7.1 Blood Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.8 Kidney Cancer
5.1.8.1 Kidney Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.9 Liver Cancer
5.1.9.1 Liver Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.10 Pancreatic Cancer
5.1.10.1 Pancreatic Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.11 Ovarian Cancer
5.1.11.1 Ovarian Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.12 Others
5.1.12.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 6 Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type
6.1 Cancer Diagnostics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 North America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.3.2 UK
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.4.2 Japan
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4.3 China
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market Estimates & forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.6.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Abbott
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Qiagen
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Siemens Healthcare GmbH
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Hologic,Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Koninklijke Philips N.V.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Illumina, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Penetration & Growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Cancer Diagnostics Market product outlook key takeaways
FIG. 16 Cancer Diagnostics: Screening Type movement analysis
FIG. 17 Laboratory Tests Market, 2014 - 2025 (USDBillion)
FIG. 18 Genetic Tests Market, 2014 - 2025 (USD Billion)
FIG. 19 Imaging Market, 2014 - 2025 (USD Billion)
FIG. 20 Endoscopy Market, 2014 - 2025 (USD Billion)
FIG. 21 BiopsyMarket, 2014 - 2025 (USD Billion
FIG. 22 Others Market, 2014 - 2025 (USDBillion)
FIG. 23 Cancer Diagnostics market Application outlook key takeaways
FIG. 24 Cancer Diagnostics : Application movement analysis
FIG. 25 Breast Cancer Market, 2014 - 2025 (USD Billion)
FIG. 26 Colorectal Cancer Market, 2014 - 2025 (USD Billion)
FIG. 27 Cervical Cancer Market, 2014 - 2025 (USD Billion)
FIG. 28 Lung Cancer Market, 2014 - 2025 (USD Billion)
FIG. 29 Prostate Cancer Market, 2014 - 2025 (USD Billion)
FIG. 30 Skin Cancer Market, 2014 - 2025 (USDBillion)
FIG. 31 Blood Cancer Market, 2014 - 2025 (USDBillion)
FIG. 32 Kidney Cancer Market, 2014 - 2025 (USD Billion)
FIG. 33 Liver Cancer Market, 2014 - 2025 (USD Billion)
FIG. 34 Pancreatic Cancer Market, 2014 - 2025 (USD Billion)
FIG. 35 Ovarian Cancer Market, 2014 - 2025 (USD Billion)
FIG. 36 Others Market, 2014 - 2025 (USD Billion)
FIG. 37 Regional market place: Key takeaways
FIG. 38 Strategy framework
FIG. 39 Participant categorization

List of Tables

TABLE 1 North America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 2 North America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 3 U.S. Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 4 U.S. Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 5 Canada Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 6 Canada Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 7 Europe Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 8 Europe Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 9 UK Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 10 UK Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 11 Germany Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 12 Germany Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 13 Asia Pacific Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 14 Asia Pacific Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 15 Japan Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion);
TABLE 16 Japan Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 17 China Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 18 China Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 19 Latin America Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 20 Latin America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 21 Brazil Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USDBillion)
TABLE 22 Brazil Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 23 Mexico Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 24 Mexico Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 25 MEA Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 26 MEA Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 27 South Africa Cancer Diagnostics Market, By Screening type, 2014 - 2025 (USD Billion)
TABLE 28 South Africa Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ がん診断の世界市場分析:タイプ別(臨床検査、遺伝検査、画像検査、内視鏡検査)、用途別(乳房、肺、肝臓、子宮頸、結腸直腸、皮膚)、地域別、セグメント予測、2014 – 2025(Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014-2025 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆